Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Paul Scorer
Concordance Among Four Commercially Available, Validated Programmed Cell Death Ligand-1 Assays in Urothelial Carcinoma
Diagnostic Pathology
Forensic Medicine
Medicine
Pathology
Histology
Related publications
Predictive Role of Computed Tomography Texture Analysis in Patients With Metastatic Urothelial Cancer Treated With Programmed Death-1 and Programmed Death-Ligand 1 Inhibitors
European urology oncology
Oncology
Radiology
Urology
Nuclear Medicine
Imaging
Surgery
Anti-Programmed Cell Death Protein-1/Ligand-1 Therapy in Different Cancers
British Journal of Cancer
Cancer Research
Oncology
Increased Programmed Death Ligand-1 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients
OncoTargets and Therapy
Oncology
Pharmacology
Programmed Death Ligand 1 in Non-Clear Cell Renal Cell Carcinoma and Correlation With Tumor Microenvironment and Prognostic Factors
Medical Journal of Islamic World Academy of Sciences
Molecular Pathways: Next-Generation Immunotherapy--Inhibiting Programmed Death-Ligand 1 and Programmed Death-1
Clinical Cancer Research
Cancer Research
Oncology
The Expression of Programmed Death Ligand-1 Within Stages of Oral Squamous Cell Carcinoma: Immunohistochemical Analysis
Journal of Advances in Medicine and Medical Research
Comprehensive Immunohistochemical Study of Programmed Cell Death Ligand 1 (PD-L1)
American Journal of Surgical Pathology
Anatomy
Forensic Medicine
Pathology
Surgery
Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Immunotherapy
JAMA Dermatology
Dermatology
Medicine
Programmed Cell Death-1/Programmed Death-Ligand 1 Blockade Improves Survival of Animals With Sepsis: A Systematic Review and Meta-Analysis
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
